Cargando…
Attitudes of patients with a rheumatic disease on drug use in the COVID-19 pandemic
BACKGROUND: Anti-rheumatic drugs can increase the predisposition to infection, and patients may be unaware of continuing their treatment during the COVID-19 pandemic. OBJECTIVE: This study aimed to assess whether patients maintain their treatment for rheumatic conditions during the pandemic period a...
Autores principales: | Coskun, Belkıs Nihan, Yagiz, Burcu, Pehlivan, Yavuz, Dalkilic, Ediz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414473/ https://www.ncbi.nlm.nih.gov/pubmed/34479631 http://dx.doi.org/10.1186/s42358-021-00211-6 |
Ejemplares similares
-
Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
por: Coşkun, Belkıs Nihan, et al.
Publicado: (2022) -
The effects of COVID-19 infection on the mortality of patients receiving rituximab therapy
por: Ekin, Ali, et al.
Publicado: (2022) -
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
por: Alpay Kanıtez, Nilüfer, et al.
Publicado: (2022) -
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
por: KALYONCU, Umut, et al.
Publicado: (2021) -
Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy
por: Pehlivan, Özlem, et al.
Publicado: (2022)